Variant report

Variant	rs7653682
Chromosome Location	chr3:46029271-46029272
allele	A/G
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:3)
CpG islands
(count:0)
Chromatin interactive
region (count:6)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:3 , 50 per page) page: 1

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	POLR2A	chr3:46029138-46029417	HUVEC	blood vessel:	n/a	n/a
2	POLR2A	chr3:46028886-46029623	HUVEC	blood vessel:	n/a	n/a
3	POLR2A	chr3:46029057-46029419	HUVEC	blood vessel:	n/a	n/a

No data

(count:6 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr3:45992659..45994641-chr3:46028942..46030792,2	K562	blood:
2	chr3:46021917..46024700-chr3:46027716..46030169,2	MCF-7	breast:
3	chr3:46024602..46026106-chr3:46028613..46030507,2	MCF-7	breast:
4	chr3:46028019..46029570-chr3:46035343..46037600,2	MCF-7	breast:
5	chr3:45986089..45986960-chr3:46029015..46029526,2	MCF-7	breast:
6	chr3:46026501..46029475-chr3:46032165..46035137,4	MCF-7	breast:

No data

Variant related genes	Relation type
FYCO1	TF binding region
ENSG00000163820	Chromatin interaction
ENSG00000172215	Chromatin interaction

Extended variants
information (count: 42 )
Associated
traits (count: 0)

rSNPs within LD-proxies of this variant (count:38)

rs_ID	r²[population]
rs1388605	1.00[CEU][hapmap];0.83[EUR][1000 genomes]
rs1388606	0.83[EUR][1000 genomes]
rs1388608	0.83[EUR][1000 genomes]
rs1392288	0.91[CEU][hapmap];0.90[EUR][1000 genomes]
rs1463680	0.83[CEU][hapmap]
rs1491949	0.83[EUR][1000 genomes]
rs1546076	1.00[CEU][hapmap];0.82[EUR][1000 genomes]
rs1566419	0.83[EUR][1000 genomes]
rs1809733	1.00[CEU][hapmap];0.83[EUR][1000 genomes]
rs1826342	0.83[EUR][1000 genomes]
rs1873616	0.82[EUR][1000 genomes]
rs2101446	0.99[EUR][1000 genomes]
rs2373148	0.95[CEU][hapmap]
rs2373149	0.83[EUR][1000 genomes]
rs2373152	0.82[EUR][1000 genomes]
rs2373155	0.91[CEU][hapmap]
rs4682801	1.00[CEU][hapmap];0.92[YRI][hapmap];0.97[AFR][1000 genomes];1.00[AMR][1000 genomes];0.98[EUR][1000 genomes]
rs4682811	0.82[EUR][1000 genomes]
rs4683158	1.00[CEU][hapmap];0.97[EUR][1000 genomes]
rs4683177	0.83[EUR][1000 genomes]
rs6441938	0.83[EUR][1000 genomes]
rs6767559	0.83[EUR][1000 genomes]
rs6786959	0.95[CEU][hapmap]
rs6802312	1.00[CEU][hapmap];0.92[YRI][hapmap];0.96[AFR][1000 genomes];0.98[AMR][1000 genomes];1.00[EUR][1000 genomes]
rs6807578	0.81[EUR][1000 genomes]
rs6808712	0.83[EUR][1000 genomes]
rs6809223	0.95[CEU][hapmap]
rs7610953	0.83[EUR][1000 genomes]
rs7622333	0.95[CEU][hapmap];0.83[EUR][1000 genomes]
rs7625348	0.83[EUR][1000 genomes]
rs7638309	0.95[CEU][hapmap]
rs902760	0.83[EUR][1000 genomes]
rs904634	0.98[EUR][1000 genomes]
rs9311388	0.83[EUR][1000 genomes]
rs9820016	1.00[CEU][hapmap];0.83[EUR][1000 genomes]
rs9849771	0.81[EUR][1000 genomes]
rs9869458	0.83[EUR][1000 genomes]
rs9875616	0.83[CEU][hapmap]

Variant overlapped rSNPs/rCNVs (count:4 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv876734	chr3:45725031-46468467	Weak transcription Enhancers Active TSS Flanking Active TSS Genic enhancers Bivalent/Poised TSS Strong transcription Bivalent Enhancer Flanking Bivalent TSS/Enh ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	42 gene(s)	inside rSNPs	diseases
2	nsv498008	chr3:45733423-46319401	Strong transcription Active TSS Genic enhancers Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	29 gene(s)	inside rSNPs	diseases
3	esv2756987	chr3:46016464-46120400	Enhancers Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh Active TSS Strong transcription Genic enhancers Bivalent Enhancer Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA	11 gene(s)	inside rSNPs	diseases
4	esv2759145	chr3:46016464-46120400	Flanking Active TSS Strong transcription Enhancers Weak transcription Active TSS Bivalent Enhancer Genic enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA	11 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:127 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr3:46000000-46029600	Weak transcription	ES-WA7 Cell Line	embryonic stem cell
2	chr3:46010200-46029600	Weak transcription	Placenta Amnion	Placenta Amnion
3	chr3:46010200-46033000	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
4	chr3:46013600-46034000	Genic enhancers	Fetal Thymus	thymus
5	chr3:46019400-46030000	Strong transcription	Primary hematopoietic stem cells short term culture	blood
6	chr3:46020000-46034200	Genic enhancers	Dnd41	blood
7	chr3:46021400-46036200	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
8	chr3:46021600-46034000	Weak transcription	ES-I3 Cell Line	embryonic stem cell
9	chr3:46023000-46029800	Strong transcription	Primary T cells from cord blood	blood
10	chr3:46025000-46029400	Genic enhancers	Fetal Intestine Small	intestine
11	chr3:46025000-46031600	Weak transcription	Fetal Kidney	kidney
12	chr3:46025200-46031800	Enhancers	Right Atrium	heart
13	chr3:46025600-46032400	Enhancers	Stomach Mucosa	stomach
14	chr3:46025600-46033000	Enhancers	Right Ventricle	heart
15	chr3:46025800-46031200	Enhancers	HSMMtube	muscle
16	chr3:46026000-46031800	Enhancers	NHDF-Ad	bronchial
17	chr3:46026200-46029800	Flanking Active TSS	Stomach Smooth Muscle	stomach
18	chr3:46026200-46031800	Weak transcription	Primary T killer naive cells fromperipheralblood	blood
19	chr3:46026200-46032000	Enhancers	Ovary	ovary
20	chr3:46026200-46032000	Flanking Active TSS	Skeletal Muscle Female	skeletal muscle
21	chr3:46026200-46032000	Enhancers	NHLF	lung
22	chr3:46026400-46029400	Weak transcription	iPS-15b Cell Line	embryonic stem cell
23	chr3:46026400-46029400	Enhancers	Fetal Lung	lung
24	chr3:46026400-46031400	Enhancers	HSMM	muscle
25	chr3:46026400-46031600	Enhancers	Fetal Intestine Large	intestine
26	chr3:46026400-46031800	Enhancers	Fetal Muscle Leg	muscle
27	chr3:46026400-46033800	Weak transcription	iPS-20b Cell Line	embryonic stem cell
28	chr3:46026400-46034600	Genic enhancers	Primary T cells fromperipheralblood	blood
29	chr3:46026600-46029400	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
30	chr3:46026600-46029600	Weak transcription	HUES6 Cell Line	embryonic stem cell
31	chr3:46026600-46029800	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
32	chr3:46026600-46030000	Enhancers	Colonic Mucosa	Colon
33	chr3:46026600-46031400	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
34	chr3:46026600-46031400	Enhancers	Lung	lung
35	chr3:46026600-46031600	Enhancers	Pancreas	Pancrea
36	chr3:46026600-46031800	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
37	chr3:46026600-46032200	Enhancers	Liver	Liver
38	chr3:46026600-46032200	Enhancers	Duodenum Mucosa	Duodenum
39	chr3:46026600-46033000	Weak transcription	iPS-18 Cell Line	embryonic stem cell
40	chr3:46026600-46033000	Weak transcription	Primary B cells from peripheral blood	blood
41	chr3:46026600-46033000	Weak transcription	Primary T cells effector/memory enriched fromperipheralblood	blood
42	chr3:46026600-46036200	Enhancers	Left Ventricle	heart
43	chr3:46026800-46029800	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
44	chr3:46026800-46032800	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Female	--
45	chr3:46026800-46033400	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
46	chr3:46026800-46033600	Weak transcription	Primary hematopoietic stem cells	blood
47	chr3:46026800-46033800	Weak transcription	HUES48 Cell Line	embryonic stem cell
48	chr3:46026800-46035600	Weak transcription	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
49	chr3:46027000-46029800	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
50	chr3:46027000-46030000	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links